ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,221.42
-0.02%
US Tech 100
17,733.60
0.06%
다우존스 지수
39,431.51
-0.21%
Bitcoin
61,855.12
-1.67%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Tyra Biosciences Inc (TYRA)

  7. Tyra Biosciences Inc (TYRA) 뉴스

TYRA Tyra Biosciences Inc

18.50
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:16:23
15분 지연
기업명 주식 심볼 시장 주식 타입
Tyra Biosciences Inc TYRA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 18.50 17:16:23
개장가 저가 고가 종가 전일 종가
18.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/05/202405:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202405:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/05/202405:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202405:08EDGAR2Form 8-K - Current report
10/05/202405:05PRNUSTyra Biosciences Reports First Quarter 2024 Financial..
08/05/202405:34EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/05/202405:29EDGAR2Form 8-K - Current report
08/05/202405:05PRNUSTyra Biosciences Announces Appointments of Susan Moran,..
20/03/202405:05PRNUSTyra Biosciences Reports Fourth Quarter and Full Year 2023..
09/03/202407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:05PRNUSTyra Biosciences to Present at Upcoming Investor Conferences
15/02/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202406:36EDGAR2Form D - Notice of Exempt Offering of Securities
13/02/202406:46EDGAR2Form 144 - Report of proposed sale of securities
10/02/202409:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202406:05PRNUSTyra Biosciences to Present at Oppenheimer's 34th Annual..
07/02/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:56EDGAR2Form 144 - Report of proposed sale of securities
05/02/202420:05EDGAR2Form 8-K - Current report
03/02/202407:04EDGAR2Form 144 - Report of proposed sale of securities
02/02/202422:00PRNUSTyra Biosciences, Inc. Announces $200 Million Private..
02/02/202407:30PRNUSTyra Biosciences Receives FDA Rare Pediatric Disease..
02/02/202407:24EDGAR2Form 8-K - Current report
22/12/202323:00EDGAR2Form 8-K - Current report
22/12/202323:00PRNUSTyra Biosciences Doses First Patient with TYRA-200 and..
09/11/202306:05PRNUSTyra Biosciences to Participate in 2023 Jefferies London..
08/11/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:07EDGAR2Form 8-K - Current report
08/11/202306:05PRNUSTyra Biosciences Reports Third Quarter 2023 Financial..
27/10/202305:50EDGAR2Form 8-K - Current report
21/09/202321:00PRNUSTyra Biosciences Announces Oral Presentations on TYRA-300..
20/09/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:05PRNUSTyra Biosciences to Participate at 2023 Cantor Global..
11/08/202305:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:21EDGAR2Form 8-K - Current report
11/08/202305:05PRNUSTyra Biosciences Reports Second Quarter 2023 Financial..
02/08/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/08/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/08/202321:54DJNTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in..
01/08/202321:00PRNUSTyra Biosciences Announces FDA Orphan Drug Designation for..
22/07/202309:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/07/202308:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/07/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202309:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/05/202321:00PRNUSTyra Biosciences to Participate in Upcoming Investor..

최근 히스토리

NASDAQ
TYRA
Tyra Biosciences
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유